These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27578036)

  • 1. A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
    Nagamata S; Ebina Y; Yamano Y; Miyamoto T; Nishijima M; Yamada H
    Kobe J Med Sci; 2016 Jul; 62(2):E45-8. PubMed ID: 27578036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
    Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
    Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas.
    Tantari M; Barra F; Di Domenico S; Ferraioli D; Vellone VG; De Cian F; Ferrero S
    Expert Opin Pharmacother; 2019 Apr; 20(6):713-723. PubMed ID: 30724615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
    Gelderblom H; Judson IR; Benson C; Merimsky O; Grignani G; Katz D; Freivogel KW; Stein D; Jobanputra M; Mungul A; Manson SC; Sanfilippo R
    Acta Oncol; 2017 Dec; 56(12):1769-1775. PubMed ID: 28723233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study.
    Sunar V; Korkmaz V; Akin S; Can Guven D; Arik Z; Ates O; Yilmaz M; Mutlu Meydanli M; Oksuzoglu B
    J BUON; 2019; 24(6):2327-2332. PubMed ID: 31983102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adjuvant therapy in uterine leiomyosarcoma.
    Ducie JA; Leitao MM
    Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel.
    Kudelka AP; Termrungruanglert W; Vadhan-Raj S; Edwards CL; Varma DG; Tornos C; Verschraegen CF; Kavanagh JJ
    Anticancer Drugs; 1996 Nov; 7(8):885-9. PubMed ID: 8991194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study.
    Kim HJ; Kim Y; Lee SJ; Lee J; Park SH
    J Gynecol Oncol; 2018 Jan; 29(1):e3. PubMed ID: 29185261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.
    Ferrero S; Leone Roberti Maggiore U; Aiello N; Barra F; Ditto A; Bogani G; Raspagliesi F; Lorusso D
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):881-889. PubMed ID: 28678537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic lung tumor from uterine leiomyosarcoma].
    Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
    Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged oral etoposide for advanced uterine leiomyosarcoma with pulmonary metastases: case report.
    Termrungruanglert W; Kudelka AP; Piamsomboon S; Edwards CL; Tornos C; Kavanagh JJ
    Eur J Gynaecol Oncol; 1997; 18(2):97-100. PubMed ID: 9105854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases].
    Murakami J; Hori K; Okubo R; Miyagi K; Shiomi M; Uragami K; Nakagawa M; Yoshioka E; Tsuruta T; Tashima R; Ito K
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):259-61. PubMed ID: 27067695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).
    O'Brien ME; Gaafar R; Hasan B; Menis J; Cufer T; Popat S; Woll PJ; Surmont V; Georgoulias V; Montes A; Blackhall F; Hennig I; Schmid-Bindert G; Baas P;
    Eur J Cancer; 2015 Aug; 51(12):1511-28. PubMed ID: 26074395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary metastasis of uterine leiomyosarcoma 8 years after hysterectomy; report of a case].
    Funada T; Ohno N; Noguchi T; Kamakari K; Terada Y
    Kyobu Geka; 2004 Jun; 57(6):509-12. PubMed ID: 15202276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine leiomyosarcoma metastasizing to the heart.
    Tunio MA; Al-Asiri M; Fareed MM
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S20-1. PubMed ID: 24717993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial Lung Disease Induced by Pazopanib Treatment.
    Ide S; Sakamoto N; Hara S; Hara A; Kakugawa T; Nakamura Y; Futsuki Y; Izumikawa K; Ishimatsu Y; Yanagihara K; Mukae H
    Intern Med; 2017; 56(1):79-83. PubMed ID: 28050004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment for uterine leiomyosarcomas.
    Gadducci A; Guerrieri ME
    Expert Opin Pharmacother; 2015 Feb; 16(3):335-46. PubMed ID: 25418060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
    Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
    Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
    Koca S; Beşiroğlu M; Özçelik M; Karaca M; Bilici M; Hacıoğlu B; Doğu GG; Kaplan NB; Oruç Z; Aydın D; Dane F
    J Oncol Pharm Pract; 2021 Apr; 27(3):541-546. PubMed ID: 32419618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.